Browse by author
Lookup NU author(s): Mark Green, Dr Sheila Waugh
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
The aim of this work was to develop and validate an algorithm to monitor rates of, and response to, treatment of patients infected with hepatitis C virus (HCV) across England using routine laboratory HCV RNA testing data. HCV testing activity between January 2002 and December 2011 was extracted from the local laboratory information systems of a sentinel network of 23 laboratories across England. An algorithm based on frequency of HCV RNA testing within a defined time period was designed to identify treated patients. Validation of the algorithm was undertaken for one center by comparison with treatment data recorded in a clinical database managed by the Trent HCV Study Group. In total, 267,887 HCV RNA test results from 100,640 individuals were extracted. Of these, 78.9% (79,360) tested positive for viral RNA, indicating an active infection, 20.8% (16,538) of whom had a repeat pattern of HCV RNA testing suggestive of treatment monitoring. Annual numbers of individuals treated increased rapidly from 468 in 2002 to 3,295 in 2009, but decreased to 3,110 in 2010. Approximately two thirds (63.3%; 10,468) of those treated had results consistent with a sustained virological response, including 55.3% and 67.1% of those with a genotype 1 and non-1 virus, respectively. Validation against the Trent clinical database demonstrated that the algorithm was 95% sensitive and 93% specific in detecting treatment and 100% sensitive and 93% specific for detecting treatment outcome. Conclusions: Laboratory testing activity, collected through a sentinel surveillance program, has enabled the first country-wide analysis of treatment and response among HCV-infected individuals. Our approach provides a sensitive, robust, and sustainable method for monitoring service provision across England. © 2013 The Authors. Hepatology published by Wiley on behalf of the American Association for the Study of Liver Diseases.
Author(s): Lattimore S, Irving W, Collins S, Penman C, Ramsay M, Jalal H, Matthews M, Smith R, Ashley C, Muir P, Atkins M, Green M, Mayoh L, Croall J, Vicca T, Locklan J, Waugh S, Ijaz S, Ngui SL, Tedder R, Vallapil M, Boxall E, Mowbray J, Lewis D, Hale A, Henderson R, Johnson D, Zuckerman M, Blackley A, Klapper P, Longbone M, Ibrahim MOH, Prichett L, Silles J, Hesketh L, Ashton PL, Hart I, Oliver T, Couto-Parada X, Al-Ghusein H, Rice P, Hewitt G, Underhill G, Kidd M, Luton P, Baker M, Nash J
Publication type: Article
Publication status: Published
Journal: Hepatology
Year: 2014
Volume: 59
Issue: 4
Pages: 1343-1350
Print publication date: 01/04/2014
Online publication date: 28/02/2014
Acceptance date: 06/11/2013
Date deposited: 28/07/2017
ISSN (print): 0270-9139
ISSN (electronic): 1527-3350
Publisher: John Wiley and Sons Ltd
URL: https://doi.org/10.1002/hep.26926
DOI: 10.1002/hep.26926
PubMed id: 24214920
Altmetrics provided by Altmetric
